On-demand, featuring presentation and speaker Q&A: Dr Rob Andrews will share his knowledge and guidance on how to support your patients with their weight management using evidenced guidance on food balance, creating calorie awareness and sustaining good eating habits.
A full list of all upcoming Diabetes events can also be viewed at the official Diabetes National Networking Forum website.
Enabling you to implement practical advice and support your patients
Key content covered during the 30 minute presentation and 30 minute Q&A:
Support and guidance for you in your own time
Packed with examples that will help you support your patients lose or maintain weight, plus benefit from:
| 1 hour video | Filmed on Monday 18th May 2020 | featuring: | |
|
Leader's introduction
|
|
|
Supporting Patients' Weight Management in Isolation
Rob Andrews, Associate Professor of Diabetes and Endocrinology, University of Exeter Medical School
|
|
|
Questions and answers with Rob Andrews
Rob will be answering the questions and comments that came into the chat box during the presentation, engaging with the thoughts and feelings of the diabetes professionals who attended this webinar live.
|
|
First-hand speaker experience
Rob is an associate Professor of Diabetes at the University of Exeter and an Honorary Consultant Physician at Musgrove Park Hospital Taunton.
At Musgrove park hospital Rob is the Clinical lead for obesity. In this role he has overseen the development of one of the largest multidisciplinary obesity services in the country. This is a holistic service offering specialised dietary and exercise programs, drug therapy and bariatric surgery as well as running clinics for people with eating disorders and complications post surgery. In recognition of this service Taunton has been designated an International Centre of Excellence for Bariatric Surgery, one of only 2 European centres to achieve this status. Rob also runs specialist adult, adolescent and paediatric sports clinics to give advice to sports men, women and children who have Type 1 diabetes.
At the University Rob concentrates on conducting clinical studies to determine the best ways to prevent and manage Type 1 and Type 2 diabetes. He has over 25 years experience of running clinical trials. These trials range from first in man studies to very large RCTs. Past clinical trials that he has conducted include: the Early ACTID study the world largest diet and exercise study in patients with Newly diagnosed Type 2 diabetes: the STAMP 2 study which examined the role that sedentary time had in the metabolic characteristics of patients with Type 2 diabetes; and the EXTOD study, the first study to examine whether regular exercise can protect beta cell function in patients with newly diagnosed Type 1 diabetes. He has also been involved in a number of investigator lead CTIMP studies in this area these include the first in man study to look at the effect of blocking 11B-HSD on insulin resistance in patients with Type 2 diabetes and a study to examine the safety and immune effects of immunotherapy with proinsulin peptide in new-onset type 1 diabetes.